Has Manish Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $83,613 in general payments to Manish Patel, MD across 103 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Manish Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Manish Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Manish Patel, MD

Urology · Charlotte, NCNPI 1558655936

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (57.7%), education and travel and lodging — rather than concentrated in one kind of arrangement. Coloplast accounts for 91.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $44,870 and has fallen 99.1% since, to $419 in 2025. Among urology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$83,613in general payments, 2019–2025

Across 103 payments — averaging $811.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Coloplast$77K
Axonics, Inc.$3K
Boston Scientific$2K
Neotract Inc.$519
Lumenis, Inc$262
Olympus America Inc.$205
plus $759 from 8 others

What the payments were for

Royalty or licence$48,20758%
Consulting fees$8001%
Speaking & faculty fees$3,2624%
Travel & lodging$5,5207%
Food & beverage$4,2185%
Education$21,60626%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Coloplast	48	$76,521
Axonics, Inc.	6	$3,261
Boston Scientific	34	$2,086
Neotract Inc.	1	$519
Lumenis, Inc	1	$262
Olympus America Inc.	2	$205
Urogen Pharma, Inc.	1	$171
Agiliti Surgical, Inc.	2	$143
Ambu Inc.	1	$120
Tempus AI, Inc	1	$118
Derma Sciences, Inc.	2	$109
Medtronic	1	$54
AbbVie	1	$37
Travere Therapeutics, Inc.	2	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$83,613 in reported general payments places this provider in the 95th percentile of 434 urology providers in North Carolina.

See all urology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$87,867

Medicare patients

200

Services billed

644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Trospium Chloride	56	$2,799
Potassium Citrate ErPotassium Citrate	15	$2,481
Tamsulosin Hcl	145	$1,269
Ampicillin Trihydrate	42	$742
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	16	$497
Ondansetron OdtOndansetron	62	$490
Cefdinir	20	$442
Cephalexin	51	$433
Finasteride	34	$390
CefuroximeCefuroxime Axetil	16	$248
Ciprofloxacin Hcl	28	$242
Oxybutynin Chloride	34	$240
Fluconazole	15	$230
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	24	$162
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	35	$139

Paid to pharmacies, not to this prescriber.

Other urology in Charlotte

Michael KennellyCharlotte$1.3M
Kris GastonCharlotte$32K
Todd CohenCharlotte$18K
Ornob RoyCharlotte$17K
Maxim McKibbenCharlotte$15K
Robert LippittSmithfield$11.4M
John KasparRaleigh$1.1M
Judd MoulDurham$1M
Daniel GeorgeDurham$1M
Scott MacdiarmidGreensboro$774K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →